Johnson & Johnson Deemed Stable and 4 Stock Analyses to Watch

Johnson & Johnson (NYSE:JNJ): RBC Capital believes that investors have become concerned about seasonality and weaker utilization trends which have affected a number of Johnson & Johnson’s peers. However, the firm thinks that Johnson & Johnson’s end markets are stable, although they maintain a Sector Perform rating on the stock.

MetLife, Inc. (NYSE:MET): Sterne Agee believes that the risk/reward ratio for the life insurance sector is far less attractive heading into the third quarter than it was during the previous quarter. The firm also is concerned about the collapse of new money investment yields during the third quarter, and they recommend that investors be highly selective when investing in the sector.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

JPMorgan Chase & Co. (NYSE:JPM): After JPMorgan reported higher than expected third quarter earnings per share, Wells Fargo said that the results reinforce their confidence that JPMorgan will report higher than expected EPS in 2013 and 2014. The firm thinks that JPMorgan’s valuation remains attractive and they maintain an Outperform rating on their shares.

Ecolab Inc. (NYSE:ECL): Braid said Ecolab Inc.’s deal to acquire Champion offers solid accretion, improves their geographic, customer and technological exposure, and should provide significant synergies. Shares are Outperform rated with a $76 price target.

Cognizant Technology Solutions Corp. (NASDAQ:CTSH): Baird said Cognizant Technology Solutions Corp. should be bought on any weakness caused by less than expected second quarter results from Infosys. The firm expects mild upside to consensus on revenues when the company reports their third quarter results. Shares remain Outperform rated with a $78 price target.

Don’t Miss: Here are 5 Biopharmaceutical Companies on the Rise.